Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Nyrada (ASX:NYR): What's The Chart Setup Everyone's Debating?

Nyrada operates in the biotechnology sector, developing therapies or health technologies aimed at addressing unmet medical needs. Biotech companies are typically valued on the potential of their pipeline, the strength of their clinical data, intellectual property, and their pathway towards regulatory approval and commercialisation. …

Sonal Goyal | 22 June 2026

Cochlear (ASX:COH): Healthcare Giant Pulls Back as Investors Reassess Valuation

In the sections that follow, we examine Cochlear's business, the possible reasons COH stock has caught the market's eye, the broader medical devices and healthcare technology context, and the factors ASX investors may keep under review. None of this should be read as financial …

Aditi Sarkar | 22 June 2026

Imugene (ASX:IMU): : Is This Biotech About To Surprise The Market?

Imugene operates in the biotechnology sector, developing therapies or health technologies aimed at addressing unmet medical needs. Biotech companies are typically valued on the potential of their pipeline, the strength of their clinical data, intellectual property, and their pathway towards regulatory approval and commercialisation. …

Sonal Goyal | 22 June 2026

Aroa Biosurgery (ASX:ARX): Medical Device Stock Slides as Investors Watch Expansion Plans

Below, we break down the company's core business, the themes that may be driving attention to ARX stock, the state of the medical devices and healthcare technology sector, and the watchpoints that could matter for ASX investors. The aim is to provide balanced context …

Aditi Sarkar | 22 June 2026

4DMedical (ASX: 4DX) Draws Fresh Market Buzz as Health-Tech Investors Watch the Next Catalyst

Health technology remains one of the most innovative areas of the Australian market, and 4DMedical (ASX:4DX) has become a closely watched name because of its software-based approach to lung imaging. The company aims to provide deeper functional insights from medical scans using software and …

Aditi Sarkar | 22 June 2026

Artrya (ASX: AYA) Draws AI Health-Tech Interest as Cardiac Technology Remains on Watchlists

Artrya Limited (ASX:AYA) sits at the intersection of artificial intelligence and healthcare, making it one of the more closely watched health-tech names on the ASX. The company focuses on improving the detection of coronary artery disease through AI-powered analysis of cardiac CT scans.

Aditi Sarkar | 22 June 2026

CSL (ASX:CSL) Shares in Focus as Defensive Healthcare Rotation Puts Biotech Giant Back in Focus

After a stretch in which high-growth and cyclical stocks soaked up the spotlight, CSL is back into focus, and investors are paying attention. The reason is simple to grasp but powerful in practice. People need plasma therapies, vaccines, and treatments for chronic conditions regardless …

Aditi Sarkar | 22 June 2026

Is Clinuvel Pharmaceuticals (ASX: CUV) Expanding Beyond SCENESSE®?

Clinuvel Pharmaceuticals (ASX:CUV) has established itself as one of Australia's prominent biotechnology companies, focusing on treatments for rare disorders and pigmentary diseases. Over the years, the company has built a niche position in photomedicine through its lead therapy, SCENESSE® (afamelanotide), which is approved in …

Aditi Sarkar | 21 June 2026

Is Pro Medicus (ASX:PME) Worth Adding to Your Watchlist?

Pro Medicus Limited (ASX: PME) is a leading healthcare informatics company founded in 1983 and headquartered in Melbourne. The company provides medical imaging software and services to hospitals, imaging centres, and healthcare groups worldwide through its Visage 7 suite of products. The Visage 7 …

Aditi Sarkar | 21 June 2026

4DMedical (ASX:4DX): Is Global Expansion Strategy Enough to Put This on Your Watchlist?

4DMedical Limited (ASX:4DX) is a Melbourne-based global respiratory imaging technology company whose core product, CT:VQ, is a software platform designed to measure lung function using conventional CT scanners — without the radiation exposure or logistical complexity associated with traditional nuclear medicine ventilation-perfusion (VQ) scans. …

Sonal Goyal | 20 June 2026
Support

Hi! How can we help you today?

Loading…